SOLVENTUM CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
SOLVENTUM CORPORATION (SOLV) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $2.00M, a 99.25% decline year-over-year.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$45.00M, a 128.66% decline year-over-year.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$22.00M.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $27.00M, a 84.83% decline year-over-year.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $430.00M.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$188.00M, a 251.61% decline from fiscal 2023.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $124.00M.
- SOLVENTUM CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$297.00M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-05 | -$43.00M 10-Q · filed 2026-08-05 | -$65.00M derived: sum of 3 quarters · filed 2026-08-05 | -$38.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$45.00M 10-Q · filed 2026-05-05 | -$67.00M derived: sum of 2 quarters · filed 2026-05-05 | -$40.00M derived: sum of 3 quarters · filed 2026-05-05 | $228.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.00M derived: sum of 2 quarters · filed 2026-02-27 | $273.00M derived: sum of 3 quarters · filed 2026-08-05 | $430.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $27.00M 10-Q · filed 2025-11-06 | $295.00M derived: sum of 2 quarters · filed 2026-08-05 | $452.00M 10-Q · filed 2025-11-06 | $160.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $268.00M 10-Q · filed 2026-08-05 | $425.00M 10-Q · filed 2026-08-05 | $133.00M derived: sum of 3 quarters · filed 2026-08-05 | $311.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $157.00M 10-Q · filed 2026-05-05 | -$135.00M derived: sum of 2 quarters · filed 2026-05-05 | $43.00M derived: sum of 3 quarters · filed 2026-05-05 | $55.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$292.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$114.00M derived: sum of 2 quarters · filed 2026-02-27 | -$102.00M derived: sum of 3 quarters · filed 2026-02-27 | -$188.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $178.00M 10-Q · filed 2025-11-06 | $190.00M derived: sum of 2 quarters · filed 2025-11-06 | $104.00M 10-Q · filed 2025-11-06 | $272.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $12.00M 10-Q · filed 2025-08-08 | -$74.00M 10-Q · filed 2025-08-08 | $94.00M derived: sum of 3 quarters · filed 2026-02-27 | -$40.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$86.00M 10-Q · filed 2025-05-09 | $82.00M derived: sum of 2 quarters · filed 2026-02-27 | -$52.00M derived: sum of 3 quarters · filed 2026-02-27 | -$30.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $168.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $34.00M derived: sum of 2 quarters · filed 2026-02-27 | $56.00M derived: sum of 3 quarters · filed 2026-02-27 | $124.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$134.00M 10-Q · filed 2024-11-08 | -$112.00M derived: sum of 2 quarters · filed 2024-11-08 | -$44.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $22.00M 10-Q · filed 2024-08-09 | $90.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $68.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$297.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |